A.S.T. Planting

1.4k total citations
31 papers, 1.2k citations indexed

About

A.S.T. Planting is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A.S.T. Planting has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 9 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A.S.T. Planting's work include Lung Cancer Research Studies (9 papers), Cancer Treatment and Pharmacology (8 papers) and Cancer therapeutics and mechanisms (6 papers). A.S.T. Planting is often cited by papers focused on Lung Cancer Research Studies (9 papers), Cancer Treatment and Pharmacology (8 papers) and Cancer therapeutics and mechanisms (6 papers). A.S.T. Planting collaborates with scholars based in Netherlands, Belgium and Italy. A.S.T. Planting's co-authors include Jaap Verweij, G. Stoter, Ronald de Wit, M de Boer-Dennert, Martin J. van den Bent, M.E.L. van der Burg, JHM Schellens, Wilfried J. Graveland, Felix E. de Jongh and Jun Ma and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

A.S.T. Planting

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A.S.T. Planting Netherlands	19	681	333	254	236	182	31	1.2k
Donna Glover United States	26	855 1.3×	465 1.4×	235 0.9×	429 1.8×	162 0.9×	38	1.8k
R. Brian Mitchell United States	11	478 0.7×	518 1.6×	160 0.6×	363 1.5×	92 0.5×	17	1.4k
P. Dodion Belgium	20	446 0.7×	484 1.5×	120 0.5×	204 0.9×	101 0.6×	72	1.1k
Joseph D. McCracken United States	19	766 1.1×	217 0.7×	212 0.8×	416 1.8×	288 1.6×	35	1.4k
Joanne Halsey United States	19	1.1k 1.6×	667 2.0×	149 0.6×	298 1.3×	154 0.8×	32	1.7k
Samuel C. Blackman United States	16	695 1.0×	883 2.7×	157 0.6×	261 1.1×	133 0.7×	34	1.5k
M de Boer-Dennert Netherlands	18	806 1.2×	627 1.9×	153 0.6×	197 0.8×	357 2.0×	30	1.5k
Dolores Gallardo‐Rincón Mexico	18	524 0.8×	494 1.5×	96 0.4×	275 1.2×	165 0.9×	49	1.3k
U. Bruntsch Germany	16	319 0.5×	282 0.8×	107 0.4×	173 0.7×	198 1.1×	55	834
Charles D. Haas United States	17	301 0.4×	149 0.4×	108 0.4×	285 1.2×	210 1.2×	68	915

Countries citing papers authored by A.S.T. Planting

Since Specialization

Citations

This map shows the geographic impact of A.S.T. Planting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.S.T. Planting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.S.T. Planting more than expected).

Fields of papers citing papers by A.S.T. Planting

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.S.T. Planting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.S.T. Planting. The network helps show where A.S.T. Planting may publish in the future.

Co-authorship network of co-authors of A.S.T. Planting

This figure shows the co-authorship network connecting the top 25 collaborators of A.S.T. Planting. A scholar is included among the top collaborators of A.S.T. Planting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.S.T. Planting. A.S.T. Planting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bipat, Shandra, Maarten S. van Leeuwen, J. IJzermans, et al.. (2007). Evidence-base guideline on management of colorectal liver metastases in the Netherlands.. PubMed. 65(1). 5–14. 47 indexed citations

Jongh, Felix E. de, Ruben N. van Veen, Ronald de Wit, et al.. (2003). Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients. British Journal of Cancer. 88(8). 1199–1206. 214 indexed citations

Wagener, D. J. Th., J. Wils, T.C. Kok, et al.. (2002). Results of a randomised phase II study of cisplatin plus 5-fluorouracil versus cisplatin plus 5-fluorouracil with α-interferon in metastatic pancreatic cancer: an EORTC gastrointestinal tract cancer group trial. European Journal of Cancer. 38(5). 648–653. 21 indexed citations

Smorenburg, Carolien H., et al.. (2000). Phase II study of miltefosine 6% solution as topical treatment of skin metastases in breast cancer patients. Anti-Cancer Drugs. 11(10). 825–828. 55 indexed citations

Planting, A.S.T., G. Catimel, P.H.M. de Mulder, et al.. (1999). Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer. Annals of Oncology. 10(6). 693–700. 82 indexed citations

Pronk, L., et al.. (1998). Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours. British Journal of Cancer. 77(1). 153–158. 18 indexed citations

Wit, Ronald de, C. B. H. W. Lamers, V van Beurden, et al.. (1998). A phase I/II study of multicyclic dose-intensive chemotherapy supported with G-CSF, or G-CSF and haematopoietic progenitor cells in whole blood, in two consecutive cohorts of patients. British Journal of Cancer. 77(12). 2363–2366. 2 indexed citations

Schellens, JHM, G.J. Creemers, Paul Wissel, et al.. (1997). The bioavailability of oral GI147211 (GG211), a new topoisomerase I inhibitor. British Journal of Cancer. 76(7). 946–951. 24 indexed citations

Pronk, L., Jan H.M. Schellens, A.S.T. Planting, et al.. (1997). Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors.. Journal of Clinical Oncology. 15(3). 1071–1079. 61 indexed citations

10.

Schellens, JHM, Jun Ma, A.S.T. Planting, et al.. (1996). Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours. British Journal of Cancer. 73(12). 1569–1575. 122 indexed citations

11.

Wit, Ronald de, P.I.M. Schmitz, Jaap Verweij, et al.. (1996). Analysis of cumulative probabilities shows that the efficacy of 5HT3 antagonist prophylaxis is not maintained.. Journal of Clinical Oncology. 14(2). 644–651. 37 indexed citations

12.

Planting, A.S.T., S.H. Goey, Jan H.M. Schellens, et al.. (1996). Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic malignant melanoma. European Journal of Cancer. 32(11). 2026–2028. 7 indexed citations

13.

Ma, Jun, Jaap Verweij, A.S.T. Planting, et al.. (1995). Current sample handling methods for measurement of platinum-DNA adducts in leucocytes in man lead to discrepant results in DNA adduct levels and DNA repair. British Journal of Cancer. 71(3). 512–517. 29 indexed citations

14.

Hilkens, P.H.E., M.E.L. van der Burg, J. Moll, et al.. (1995). Neurotoxicity is not enhanced by increased dose intensities of cisplatin administration. European Journal of Cancer. 31(5). 678–681. 18 indexed citations

15.

Gaast, Ate van der, M. Bontenbal, A.S.T. Planting, T.C. Kok, & T. A. W. Splinter. (1994). Phase II study of carboplatin and etoposide as a first line regimen in patients with metastatic breast cancer. Annals of Oncology. 5(9). 858–860. 6 indexed citations

16.

Planting, A.S.T., T. A. W. Splinter, Andrea Ardizzoni, et al.. (1992). Phase II study of ACNU as second-line treatment in small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 29(5). 409–411. 7 indexed citations

17.

Rümke, P, Ulrich R. Kleeberg, R.M. MacKie, et al.. (1992). Tamoxifen as a single agent for advanced melanoma in postmenopausal women. A phase II study of the EORTC Malignant Melanoma Cooperative Group. Melanoma Research. 2(3). 153–156. 31 indexed citations

18.

Verweij, Jaap, Hans Herweijer, R. Oosterom, et al.. (1991). A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance. British Journal of Cancer. 64(2). 361–364. 59 indexed citations

19.

Planting, A.S.T., Andrea Ardizzoni, Giuseppe Giaccone, et al.. (1991). Phase II study of ACNU in non-small-cell lung cancer: EORTC study 08872. Cancer Chemotherapy and Pharmacology. 28(2). 145–146. 5 indexed citations

20.

Klijn, J.G.M., A.S.T. Planting, Jaco J. Verweij, et al.. (1990). Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects. British Journal of Cancer. 62(4). 627–630. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact